{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:33:49Z","timestamp":1776447229045,"version":"3.51.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.neurol.2020.09.015","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T08:42:32Z","timestamp":1614328952000},"page":"215-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Myasthenia gravis and pregnancy"],"prefix":"10.1016","volume":"177","author":[{"given":"P.","family":"Roche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4005-1537","authenticated-orcid":false,"given":"F.","family":"Bouhour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2020.09.015_bib0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2020.09.015_bib0180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/mus.24556","article-title":"Impact of myasthenia gravis on family planning: how do women with myasthenia gravis decide and why?","volume":"52","author":"Ohlraun","year":"2015","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.neurol.2020.09.015_bib0185","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/ene.13788","article-title":"Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence","volume":"25","author":"Gilhus","year":"2018","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2020.09.015_bib0190","first-page":"933","article-title":"Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. 1975","volume":"51","author":"Lindstrom","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2020.09.015_bib0195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/GRF.0b013e31828e92c0","article-title":"Myasthenia gravis and pregnancy","volume":"56","author":"Varner","year":"2013","journal-title":"Clin Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.neurol.2020.09.015_bib0200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.nmd.2008.03.006","article-title":"Severe neonatal myasthenia due to maternal anti-MuSK antibodies","volume":"18","author":"B\u00e9hin","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2020.09.015_bib0205","article-title":"Autoanticorps antir\u00e9cepteurs cholinergiques","author":"Fabien","year":"2012","journal-title":"EMC Biol Med"},{"issue":"5","key":"10.1016\/j.neurol.2020.09.015_bib0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12264-012-1256-0","article-title":"Clinical significance of detection of antibodies to fetal and adult acetylcholine receptors in myasthenia gravis","volume":"28","author":"Shi","year":"2012","journal-title":"Neurosci Bull"},{"issue":"5","key":"10.1016\/j.neurol.2020.09.015_bib0215","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jnnp-2013-305572","article-title":"Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group","volume":"85","author":"Norwood","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.neurol.2020.09.015_bib0220","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1038\/s41598-017-08631-5","article-title":"Balance between estrogens and pro-inflammatory cytokines regulates chemokine production involved in thymic germinal centre formation","volume":"7","author":"Dragin","year":"2017","journal-title":"Sci Rep"},{"issue":"8156\u20138157","key":"10.1016\/j.neurol.2020.09.015_bib0225","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(79)92815-0","article-title":"Significance in neonatal myasthenia gravis of inhibitory effect of amniotic fluid on binding of antibodies to acetylcholine receptor","volume":"2","author":"Abramsky","year":"1979","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.neurol.2020.09.015_bib0230","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0165-5728(87)90067-1","article-title":"Experimental myasthenia gravis induced in mice by passive transfer of human myasthenic immunoglobulin. Evidence for an ameliorating effect by alpha-fetoprotein","volume":"13","author":"Buschman","year":"1987","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.neurol.2020.09.015_bib0235","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1212\/WNL.52.3.447","article-title":"Course and treatment of myasthenia gravis during pregnancy","volume":"52","author":"Batocchi","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2020.09.015_bib0240","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nmd.2017.01.021","article-title":"Clinical follow-up of pregnancy in myasthenia gravis patients","volume":"27","author":"Ducci","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.neurol.2020.09.015_bib0245","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2004-829590","article-title":"The management of myasthenia gravis in pregnancy","volume":"24","author":"Ciafaloni","year":"2004","journal-title":"Semin Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2020.09.015_bib0250","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s11845-019-02029-0","article-title":"Myasthenia gravis and pregnancy: retrospective evaluation of 27 pregnancies in a tertiary centre and comparison with previous studies","volume":"188","author":"Tanacan","year":"2019","journal-title":"Ir J Med Sci"},{"issue":"2","key":"10.1016\/j.neurol.2020.09.015_bib0255","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ncl.2018.01.005","article-title":"An update: myasthenia gravis and pregnancy","volume":"36","author":"Johanna Hamel","year":"2018","journal-title":"Neurol Clin"},{"issue":"20","key":"10.1016\/j.neurol.2020.09.015_bib0260","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/WNL.0000000000003339","article-title":"Increased risk for clinical onset of myasthenia gravis during the postpartum period","volume":"87","author":"Boldingh","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2020.09.015_bib0265","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/mus.23882","article-title":"Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?","volume":"49","author":"Choi Decroos","year":"2014","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.neurol.2020.09.015_bib0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1468-1331.2006.01538.x","article-title":"Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care","volume":"14","author":"Hoff","year":"2007","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2020.09.015_bib0275","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1468-1331.2009.02689.x","article-title":"No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: a nationwide population-based study","volume":"16","author":"Wen","year":"2009","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2020.09.015_bib0280","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1468-1331.2004.00900.x","article-title":"Asymptomatic myasthenia gravis influences pregnancy and birth","volume":"11","author":"Hoff","year":"2004","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2020.09.015_bib0285","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/01.WNL.0000082725.21444.EC","article-title":"Myasthenia gravis: consequences for pregnancy, delivery, and the newborn","volume":"61","author":"Hoff","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurol.2020.09.015_bib0290","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/jog.13922","article-title":"Management of labour and delivery in myasthenia gravis: a new protocol","volume":"45","author":"Tsurane","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"10.1016\/j.neurol.2020.09.015_bib0295","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ncl.2018.09.003","article-title":"Management of myasthenia gravis in pregnancy","volume":"37","author":"Waters","year":"2019","journal-title":"Neurol Clin"},{"issue":"3","key":"10.1016\/j.neurol.2020.09.015_bib0300","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2249.1990.tb03296.x","article-title":"Neonatal myasthenia gravis: antigenic specificities of antibodies in sera from mothers and their infants","volume":"80","author":"Tzartos","year":"1990","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.neurol.2020.09.015_bib0305","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/WNL.38.1.138","article-title":"Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30 cases","volume":"38","author":"Morel","year":"1988","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2020.09.015_bib0310","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0165-5728(86)90028-7","article-title":"Neonatal myasthenia gravis: clinical and immunological study of seven mothers and their newborn infants","volume":"12","author":"Bartoccioni","year":"1986","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.neurol.2020.09.015_bib0315","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1212\/WNL.48.1.50","article-title":"The fetal\/adult acetylcholine receptor antibody ratio in mothers with myasthenia gravis as a marker for transfer of the disease to the newborn","volume":"48","author":"Gardnerova","year":"1997","journal-title":"Neurology"},{"issue":"8966","key":"10.1016\/j.neurol.2020.09.015_bib0320","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(95)92652-6","article-title":"Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen","volume":"346","author":"Vincent","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neurol.2020.09.015_bib0325","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1212\/NXI.0000000000000057","article-title":"Fetal acetylcholine receptor inactivation syndrome: a myopathy due to maternal antibodies","volume":"2","author":"Hacohen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"10.1016\/j.neurol.2020.09.015_bib0330","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1212\/01.wnl.0000278101.95510.09","article-title":"Isolated facial and bulbar paresis: a persistent manifestation of neonatal myasthenia gravis","volume":"70","author":"Jeannet","year":"2008","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.neurol.2020.09.015_bib0335","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1212\/01.wnl.0000307751.20968.f1","article-title":"A transient neonatal myasthenic syndrome with anti-musk antibodies","volume":"70","author":"Niks","year":"2008","journal-title":"Neurology"},{"issue":"1 Neurology of Pregnancy","key":"10.1016\/j.neurol.2020.09.015_bib0340","first-page":"115","article-title":"Pregnancy and myasthenia gravis","volume":"20","author":"Massey","year":"2014","journal-title":"Contin Minneap Minn"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:40:53Z","timestamp":1758519653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378721000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0035378721000278"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2020.09.015","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myasthenia gravis and pregnancy","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2020.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}